EU drug regulators approve Moderna vaccine

2021-01-06 at 20:06

The European Union drugs regulator has recommended granting Moderna’s Covid-19 vaccine a conditional marketing authorization — a move that paves the way for it to become the second coronavirus vaccine distributed in the bloc.

Following the recommendation by the European Medicines Agency (EMA), the drug must be formally authorized by the European Commission; this is expected to happen quickly.

Moderna’s coronavirus vaccine is similar to the Pfizer-BioNTech vaccine, the first Covid-19 vaccine approved for use in the EU.

But there are a few key differences.

Most importantly, Moderna’s vaccine can be stored in normal freezers and does not require a super-cold transportation network, making it more accessible for smaller facilities and local communities.